Kramer I, Konig L, Brecht A, Hassel JC, et al. Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with cutaneous T-cell lymphoma. Bone Marrow Transplant 2026 Jan 20. doi: 10.1038/s41409-025-02796.
PMID: 41559396